G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms

High Blood Press Cardiovasc Prev. 2013 Mar;20(1):5-12. doi: 10.1007/s40292-013-0001-8. Epub 2013 Mar 27.

Abstract

Numerous factors partake in the fine-tuning of arterial blood pressure. The heptahelical G-protein-coupled receptors (GPCRs) represent one of the largest classes of cell-surface receptors. Further, ligands directed at GPCRs account for nearly 30 % of current clinical pharmaceutical agents available. Given the wide variety of GPCRs involved in blood pressure control, it is reasonable to speculate for a potential role of established intermediaries involved in the GPCR desensitization process, like the G-protein-coupled receptor kinases (GRKs), in the regulation of vascular tone. Of the seven mammalian GRKs, GRK2 seems to be the most relevant isoform at the cardiovascular level. This review attempts to assemble the currently available information concerning GRK2 and hypertension, opening new potential fields of translational investigation to treat this vexing disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Arterial Pressure*
  • Endothelium, Vascular / enzymology*
  • Endothelium, Vascular / physiopathology
  • G-Protein-Coupled Receptor Kinase 2 / metabolism*
  • Humans
  • Hypertension / enzymology*
  • Hypertension / physiopathology
  • Receptors, Adrenergic / metabolism*
  • Signal Transduction
  • Up-Regulation
  • Vasodilation

Substances

  • Receptors, Adrenergic
  • G-Protein-Coupled Receptor Kinase 2